Results 211 to 220 of about 331,841 (258)

Maraviroc Inhibits SARS-CoV-2 Through Variant-Dependent Effects on Viral Entry and Mpro Activity Using Single-Round Infectious Particle and Virus-like Particle Models. [PDF]

Viruses
Le UNP, Chen PJ, Chu LW, Arifin JC, Chen CH, Chen YH, Su WC, Hsueh PR, Ping YH, Lin CW.   +9 more
europepmc   +1 more source

Point of Care Testing and Recombinase Polymerase Amplification

Journal of Clinical Laboratory Analysis, EarlyView.
Manfred Weidmann, Ahmed Abd El Wahed
wiley   +1 more source

Molecular epidemiology of respiratory viral infections in hospitalized children in Novosibirsk, Russia, 2021-2023. [PDF]

Front Pediatr
Maslov DE, Osipov ID, Zabelina DS, Demina DS, Tomilova YE, Berdieva SB, Makukha VV, Komissarova TV, Agletdinov EF, Netesov SV.   +9 more
europepmc   +1 more source

Treatment and Diagnostic Challenges in a Patient with Atypical SARS-CoV-2-Associated Encephalitis Mimicking a Neoplasm: A Case Report. [PDF]

Reports (MDPI)
Theologou M, Kyriakongonas P, Syrmos N, Theologou T.   +3 more
europepmc   +1 more source

Changing virulence of the SARS virus: the epidemiological evidence.

Bulletin of the World Health Organization, 2004
Ming-Dong Wang, Ann Margaret Jolly
openaire   +2 more sources

Respiratory Outbreak Mitigation With Point-of-Care Testing in Long-Term Care: A Randomized Clinical Trial.

JAMA Intern Med
Kandel C, Oriotis D, Candon HL, Callahan J, Chan CK, Truong A, Rookwood A, Suleiman S, Rosario C, Wong BM, Palmer SJ, Pascual B, Serapion V, Marcovici L, Feldman S, Yip PM, Kozak RA, Taylor T, Sanstrom P, Kirk K, Eplett J, Chawla R, Brown KA, Brasg I, Powis J, Leis JA.   +25 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Insurance and Epidemics: SARS, West Nile Virus and Nipah Virus

Journal of Insurance Medicine, 2021
Severe acute respiratory syndrome (SARS) reminds us that sudden disease emergence is a permanent part of our world—and should be anticipated in our planning. Historically the emergence of new diseases has had little or no impact beyond a small, localized cluster of infections.
openaire   +3 more sources

SARS: Understanding the Virus and Development of Rational Therapy

Current Molecular Medicine, 2005
In late 2002 a new disease, severe atypical respiratory syndrome (SARS), emerged in China. A hitherto unknown animal coronavirus (CoV) that had crossed the species barrier through close contact of humans with infected animals was identified as the etiological agent.
K, Stadler, R, Rappuoli
openaire   +2 more sources